Pancreatic Cancer Research

ResearcherInsermNo recent work listed

Zahari Raykov

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5108409891. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: none · 2014: 2 papers

Papers 4

  1. Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy. Co-author DOI 10.1002/ijc.28597↗
  2. Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer. Co-author DOI 10.1128/jvi.03688-13↗
  3. Pancreatic cancer cell lines can induce prostaglandin e2 production from human blood mononuclear cells. Last author DOI 10.1155/2011/741868↗
  4. Interferon γ improves the vaccination potential of oncolytic parvovirus H-1PV for the treatment of peritoneal carcinomatosis in pancreatic cancer. Last author DOI 10.4161/cbt.12.10.17678↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Svitlana P. Grekova · 4 shared papers, 2011–2014 · strength 0.14
  2. Nathalia A. Giese · 3 shared papers, 2011–2014 · strength 0.11
  3. Marc Aprahamian · 3 shared papers, 2011–2014 · strength 0.11
  4. Assia L. Angelova · 3 shared papers, 2011–2014 · strength 0.10
  5. Jens Werner · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.